Quebec Randomized Controlled Trial on Prostate Cancer Screening Shows No Evidence for Mortality Reduction

Published in: Prostate, Vol. 40, No. 2, Comment, 1999, p. 130-131

Posted on on January 01, 1999

by Rob Boer, Fritz H. Schroder

Authors comment on a recent article on primary outcomes from the trial on prostate cancer screening in Quebec. The analysis as an observational study divided the trial population according to whether men in the study population actually had a screening or not. They comment that the data from the Quebec trial do not allow for an estimate of the magnitude of the possible self-selection bias. This method of analysis should therefore not have been used, not even if the original design of this research had been an observational study instead of a randomized trial.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.